| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |